The Global Patient Recruitment & Retention Services Market: 2019 to 2030 -- Increased Offshoring of Clinical Development Operations to Emerging Regions -

DUBLIN--()--The "Patient Recruitment and Retention Services Market, 2019-2030" report has been added to's offering.

Patient Recruitment and Retention Services, 2019-2030 offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain.

One of the key objectives of the report was to estimate the existing market size and review the potential growth opportunities for patient recruitment service providers over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2019-2030.

In addition, we have segmented the future opportunity across:

  • [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others)
  • [B] steps in patient recruitment process (pre-screening and screening)
  • [C] phases of development (phase I, phase II, phase III and phase IV)
  • [D] different global regions (North America, Europe, Asia-Pacific and rest of the world)

In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry's evolution.

Market Insights

Clinical trials represent an arduous step in the drug development process and are crucial to understanding the safety and efficacy profiles of novel therapeutic interventions. As these trials are prone to delays, and can even fail altogether, they impose immense financial pressure on sponsors.

Amongst several known challenges, patient recruitment is considered to be one of the rate-limiting steps when it comes to getting drugs to the market. It is estimated that 80% of clinical trials do not meet their designated patient enrolment deadlines. In fact, around 37% of research sites fail to meet their subject accrual goals, while more than 10% don't even enroll a single patient.

In addition, retaining patients is also a matter of concern, considering that the approximate dropout rate across clinical studies is around 30%. Delays in product launch, due to inability of the sponsors to recruit/retain patients, are highly common and are estimated to result in an average loss of USD 8 million per day in opportunity costs, for a blockbuster drug.

The above-mentioned challenges have led several players in the pharmaceutical industry to outsource their patient recruitment-related needs to capable, specialty service providers. Employing contract service providers has been shown to expedite the patient recruitment process. Such service providers employ a variety of outreach methods, such as social media, mobile technologies, electronic health records (EHRs) and real-world evidence (RWE), and, over time, have attained a vital role in the successful conduct of clinical research.

Although some big pharma players carry out patient recruitment in-house, the growing complexity of clinical trials and demand for niche patient populations for studies evaluating orphan drugs/personalized medicines is likely to prompt more developer companies to outsource various aspects of their clinical research-related operations in the foreseen future.

In fact, the market has recently witnessed the establishment of several partnerships, which include agreements between study sponsors and patient recruitment firms (outsourcing deals) and partnerships between stakeholders aimed to combine their respective services portfolios related to patient recruitment and retention (service alliances). This niche services industry has also witnessed some consolidation as multiple smaller players have been acquired by more established entities, in an effort to expand geographical reach.

Key Topics Covered

1. Preface

1.1. Scope of the Report

1.2. Research Methodology

1.3. Chapter Outlines

2. Executive Summary

3. Patient Recruitment And Retention In Clinical Trials

3.1. Chapter Overview

3.2. Clinical Trials

3.2.1. Clinical Trial Phases

3.3. Patient Recruitment

3.3.1. The Patient Recruitment Process

3.3.2. Challenges Associated with Patient Recruitment

3.3.3. Strategies to Improve Patient Recruitment

3.3.4. Ethical Considerations

3.4. Outsourcing of Patient Recruitment

3.4.1. Patient Recruitment Services

3.5. Patient Retention

3.5.1. Patient Retention Services

4. Patient Outreach Methods

4.1. Chapter Overview

4.2. Patient Outreach Methods

4.2.1. Traditional Media

4.2.2. Emerging / Novel Methods

4.2.3. Best Practices / Recommendations for Patient Outreach

5. Competitive Market Landscape Of Patient Recruitment And Retention Service Providers

5.1. Chapter Overview

5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape

5.2.1. Analysis by Year of Establishment

5.2.2. Analysis by Company Size

5.2.3. Analysis by Geography

5.2.4. Analysis by Patient Recruitment and Retention Services Offered

5.2.5. Analysis by Patient Outreach Methods

5.2.6. Analysis by Patient Recruitment Associated Services

5.2.7. Analysis by Patient Retention Methods

5.2.8. Analysis by Geographical Reach

5.2.9. Analysis by Therapeutic Expertise

5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status

6. Company Competitiveness Analysis

6.1. Chapter Overview

6.2. Methodology

6.3. Assumptions and Key Parameters

6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis

6.4.1. Small-Sized Companies

6.4.2. Mid-Sized Companies

6.4.3. Large Companies

7. Company Profiles

7.1. Chapter Overview

7.2. Patient Recruitment Service Providers in North America

7.2.1. Acurian

7.2.2. BBK Worldwide

7.2.3. Bright Pharmaceuticals Services

7.2.4. ClinEdge

7.2.5. CSSi

7.2.6. CTM

7.2.7. Integrated Clinical Trial Services (ICTS)

7.2.8. MMG

7.2.9. Topstone Research

7.2.10. WCCT Global

7.3. Patient Recruitment Service Providers in Europe

7.3.1. Antidote

7.3.2. Fidelis Research

7.3.3. Ignite Data

7.3.4. Polaris BioPharma Consulting

7.3.5. Tudor Reilly Health

7.4. Patient Recruitment Services Providers in Asia Pacific

7.4.1. CROe

7.4.2. Jsure Healthmedia

7.4.3. TrialWire

7.4.4. Pacific Groove

8. Partnerships And Collaborations

8.1. Chapter Overview

8.2. Partnership Models

8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations

8.3.1. Analysis by Year of Partnerships

8.3.2. Analysis by Type of Partnership

8.3.3. Analysis by Purpose of Agreement

8.3.4. Analysis by Therapeutic Area

8.3.5. Most Active Players: Analysis by Number of Partnerships

8.3.6. Geographical Analysis

9. Recent Trends In Patient Recruitment And Retention

9.1. Chapter Overview

9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials

9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention

9.1.3. Use of EHR Data to Improve Patient Recruitment Rates

9.1.4. Other Real World Data Sources to Help Overcome Patient Recruitment-Related Challenges

9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets

10. Future Growth Opportunities

10.1. Chapter Overview

10.1.1. Anticipated Increase in the Number of Global Clinical Trials

10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine

10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions

10.1.4. Availability of Service Providers Offering One-Stop-Solutions

10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing

11. Market Sizing And Opportunity Analysis

11.1. Chapter Overview

11.2. Forecast Methodology and Key Assumptions

11.3. Overall Patient Recruitment Services Market, 2019-2030

11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030

11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030

11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030

11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030

11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030

11.7.2. Patient Recruitment Services Market in North America, 2019-2030

11.7.3. Patient Recruitment Services Market in EU5, 2019-2030

11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030

11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030

12. Conclusion

12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes

12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs

12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas

12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers

12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade

13. Interview Transcripts

13.1. Chapter Overview

13.2. Link2Trials

13.3. nRollmed

13.4. Seeker Health

Companies Mentioned (in alphabetical order)

  • Abnex
  • Access Clinical Research
  • Accurate Clinical Research
  • Acurian
  • Advanced Clinical
  • Affordable Clinical Trials Outsourcing
  • Akcelis
  • Alleco Trials
  • Alliance for Clinical Research Excellence and Safety
  • Allscripts
  • American Liver Foundation
  • American Society of Clinical Oncology
  • Amgen
  • Antidote
  • ApotheCom
  • Apparelyzed
  • Apptomics
  • AQLANE Medical
  • Arden and Schmidt
  • AstraZeneca
  • ATLAS Medical Services
  • AutoCruitment
  • AXELLE Group
  • Axiom Marketing
  • BBK Worldwide
  • BDD
  • BIAPharm
  • Bio-Optronics
  • Bioclinica
  • BioScript
  • Bladder & Bowel Community
  • Blueprint Clinical
  • BlueTheory Clinical Trials
  • BMC Group
  • Box
  • Bridge Clinical Research
  • Bright Pharmaceutical Services
  • Buzzreach
  • C&C Clinical Laboratory Consulting
  • Canadian Institute for Medical Advancement
  • Capsule Communications
  • CaringKind
  • CarthagoPharma
  • Center Point Clinical Services
  • Centricity Health
  • Chandler Chicco Agency
  • Chase Medical Research
  • Cinven
  • Circuit Clinical
  • and many more...

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials